Updated analytical report on Sanofi S.A.

Sanofi S.A.

WEDNESDAY, 19/04/2023 - Scope Ratings GmbH

Updated analytical report on Sanofi S.A.

Following the recent affirmation of the Sanofi S.A. issuer rating, Scope has updated its analytical report on Sanofi S.A.

Scope Ratings GmbH (Scope) has affirmed its AA/Stable issuer rating on French pharmaceutical company Sanofi S.A. on 11 April 2023.

This monitoring note does not constitute a rating action, nor does it indicate the likelihood of a credit rating action in the short term. The latest information on the credit ratings in this monitoring note along with the associated rating history can be found on www.scoperatings.com.

Download the report here.

Sanofi S.A.

Related news

Scope affirms Hungarian construction company DVM's B issuer rating, revises Outlook to Negative

30/4/2025 Rating announcement

Scope affirms Hungarian construction company DVM's B issuer ...

Scope downgrades IB Invest to C from CC/Stable and places it under review for a possible downgrade

29/4/2025 Rating announcement

Scope downgrades IB Invest to C from CC/Stable and places it ...

Scope affirms BBB- issuer rating on Deutsche Lufthansa and revises Outlook to Stable from Positive

28/4/2025 Rating announcement

Scope affirms BBB- issuer rating on Deutsche Lufthansa and ...

Scope proposes an update to its Retail and Wholesale Rating Methodology and invites comments

25/4/2025 Research

Scope proposes an update to its Retail and Wholesale Rating ...

Scope affirms BBB+/Stable issuer rating of Hungarian pharmaceutical Richter

25/4/2025 Rating announcement

Scope affirms BBB+/Stable issuer rating of Hungarian ...

Scope affirms the issuer rating of Sun Group at B+, assigns Stable Outlook

24/4/2025 Rating announcement

Scope affirms the issuer rating of Sun Group at B+, assigns ...